CORC  > 中国医学科学院 北京协和医学院
A MULTICENTRE, RANDOMISED, DOUBLE-BLIND, PARALLEL ACTIVE-CONTROLLED CLINICAL TRIAL COMPARING PHARMACOKINETICS, PHARMACODYNAMICS, SAFETY AND EXPLORATORY EFFICACY BETWEEN HLX01 AND EUROPE-SOURCED RITUXIMAB AS A NEW INDICATION IN CHINESE MODERATE TO
Zeng, Xiaofeng; Wang, Yongfu; Jiang, Zhenyu; Zhang, Zhuoli; He, Lan; Zhang, Xiao; Lu, Xin; Liu, Xiumei; Xu, Jian; Huang, Cibo
2019
会议名称ANNALS OF THE RHEUMATIC DISEASES
会议日期2019-06-01
页码1140-1140
收录类别CPCI-S
URL标识查看原文
内容类型会议论文
URI标识http://www.corc.org.cn/handle/1471x/6337259
专题中国医学科学院 北京协和医学院
推荐引用方式
GB/T 7714
Zeng, Xiaofeng,Wang, Yongfu,Jiang, Zhenyu,et al. A MULTICENTRE, RANDOMISED, DOUBLE-BLIND, PARALLEL ACTIVE-CONTROLLED CLINICAL TRIAL COMPARING PHARMACOKINETICS, PHARMACODYNAMICS, SAFETY AND EXPLORATORY EFFICACY BETWEEN HLX01 AND EUROPE-SOURCED RITUXIMAB AS A NEW INDICATION IN CHINESE MODERATE TO[C]. 见:ANNALS OF THE RHEUMATIC DISEASES. 2019-06-01.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace